CRMD logo

CRMD
CorMedix Inc

23,391
Mkt Cap
$584.18M
Volume
1.26M
52W High
$17.43
52W Low
$6.13
PE Ratio
3.73
CRMD Fundamentals
Price
$7.39
Prev Close
$7.13
Open
$7.27
50D MA
$6.97
Beta
1.03
Avg. Volume
1.64M
EPS (Annual)
$2.03
P/B
1.45
Rev/Employee
$1.63M
$933.71
Loading...
Loading...
News
all
press releases
Phocas Financial Corp. Takes $1.99 Million Position in CorMedix Inc $CRMD
Phocas Financial Corp. bought a new position in shares of CorMedix Inc (NASDAQ:CRMD - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange...
MarketBeat·3d ago
News Placeholder
More News
News Placeholder
CorMedix Outlines Post-Melinta Growth, Q2 REZZAYO Phase 3 Catalyst and DefenCath Reimbursement Shift
CorMedix (NASDAQ:CRMD) Chief Executive Officer Joe Todisco outlined the company's evolving strategy and upcoming catalysts during a fireside chat at Needham & Company's 25th Annual Healthcare...
MarketBeat·4d ago
News Placeholder
CorMedix Inc (NASDAQ:CRMD) Receives Average Recommendation of "Moderate Buy" from Analysts
CorMedix Inc (NASDAQ:CRMD - Get Free Report) has earned an average rating of "Moderate Buy" from the eight brokerages that are presently covering the stock, MarketBeat reports. One research analyst...
MarketBeat·8d ago
News Placeholder
Phocas Financial Corp. Takes $1.99 Million Position in CorMedix Inc $CRMD
Phocas Financial Corp. bought a new stake in shares of CorMedix Inc (NASDAQ:CRMD - Free Report) during the 4th quarter, according to its most recent filing with the SEC. The firm bought 171,087 shares of the company's stock, valued at approximately $1,990,000. Phocas Financial Corp. owned 0.22% of...
MarketBeat·13d ago
News Placeholder
Strength Seen in MeiraGTx (MGTX): Can Its 6.2% Jump Turn into More Strength?
MeiraGTx (MGTX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Zacks·19d ago
News Placeholder
Do Options Traders Know Something About CorMedix Stock We Don't?
Investors need to pay close attention to CRMD stock based on the movements in the options market lately.
Zacks·24d ago
News Placeholder
CorMedix (CRMD) Expected to Announce Earnings on Tuesday
CorMedix (NASDAQ:CRMD) will be releasing its Q4 2025 earnings before the market opens on Tuesday, March 31. (View Earnings Report at...
MarketBeat·26d ago
News Placeholder
CorMedix Inc (NASDAQ:CRMD) Given Consensus Rating of "Moderate Buy" by Brokerages
CorMedix Inc (NASDAQ:CRMD - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the eight research firms that are currently covering the stock, Marketbeat.com reports. One...
MarketBeat·1mo ago
News Placeholder
CorMedix Inc $CRMD Shares Bought by Divisadero Street Capital Management LP
Divisadero Street Capital Management LP boosted its holdings in shares of CorMedix Inc (NASDAQ:CRMD - Free Report) by 305.7% during the third quarter, according to its most recent disclosure with the...
MarketBeat·1mo ago
News Placeholder
CorMedix CEO touts Melinta pivot, DefenCath TDAPA transition and Q2 REZZAYO Phase 3 data at Leerink
CorMedix (NASDAQ:CRMD) Chief Executive Officer Joseph Todisco told attendees at the Leerink Global Healthcare Conference that the company has undergone a significant shift over the last year, moving...
MarketBeat·1mo ago
<
1
2
...
>

Latest CRMD News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.